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Abstract
Optic Atrophy 1 (OPA1) is a ubiquitously expressed dynamin-like GTPase in the inner mitochondrial membrane. It plays
important roles in mitochondrial fusion, apoptosis, reactive oxygen species (ROS) and ATP production. Mutations of OPA1
result in autosomal dominant optic atrophy (DOA). The molecular mechanisms by which link OPA1 mutations and DOA are
not fully understood. Recently, we created a Drosophila model to study the pathogenesis of optic atrophy. Heterozygous
mutation of Drosophila OPA1 (dOpa1) by P-element insertion results in no obvious morphological abnormalities, whereas
homozygous mutation is embryonic lethal. In eye-specific somatic clones, homozygous mutation of dOpa1 causes rough
(mispatterning) and glossy (decreased lens deposition) eye phenotypes in adult Drosophila. In humans, heterozygous
mutations in OPA1 have been associated with mitochondrial dysfunction, which is predicted to affect multiple organs. In
this study, we demonstrated that heterozygous dOpa1 mutation perturbs the visual function and an ERG profile of the
Drosophila compound eye. We independently showed that antioxidants delayed the onset of mutant phenotypes in ERG
and improved larval vision function in phototaxis assay. Furthermore, heterozygous dOpa1 mutation also caused decreased
heart rate, increased heart arrhythmia, and poor tolerance to stress induced by electrical pacing. However, antioxidants had
no effects on the dysfunctional heart of heterozygous dOpa1 mutants. Under stress, heterozygous dOpa1 mutations caused
reduced escape response, suggesting abnormal function of the skeletal muscles. Our results suggest that heterozygous
mutation of dOpa1 shows organ-specific pathogenesis and is associated with multiple organ abnormalities in an age-
dependent and organ-specific manner.
Citation: Shahrestani P, Leung H-T, Le PK, Pak WL, Tse S, et al. (2009) Heterozygous Mutation of Drosophila Opa1 Causes the Development of Multiple Organ
Abnormalities in an Age-Dependent and Organ-Specific Manner. PLoS ONE 4(8): e6867. doi:10.1371/journal.pone.0006867
Editor: Gregory S. Barsh, Stanford University School of Medicine, United States of America
Received April 6, 2009; Accepted June 22, 2009; Published August 31, 2009
Copyright:  2009 Shahrestani et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was partially supported by NEI 1R01EY018876-01, the Helen & Larry Hoag Foundation to TH. HTL was supported by a grant from National
Eye Institute, NIH, EY00033, awarded to WLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: huangts@uci.edu
¤ Current address: Department of Biological Sciences, Grambling State University, Grambling, Louisiana, United States of America
. These authors contributed equally to this work.
Introduction
OPA1 is encoded by a ubiquitously expressed nuclear gene and
localized in the inner mitochondrial membrane [1–3]. OPA1 consists
of a mitochondrial targeting signal (MTS), a transmembrane domain
(TMD), a presenilin-associated rhomboid-like protease (PARL) site,
and a dynamin/GTPase domain. The PARL can process OPA1,
converting the insoluble inner mitochondrial membrane protein to a
soluble protein [1,3]. OPA1 also regulates cytochrome-c mediated
apoptosis by modulating mitochondrial cristae morphology [4,5,6,7].
In humans, mutation of OPA1 causes retinal ganglion cell death and
optic atrophy [4]. The disease leads to loss of central vision and color
vision abnormalities [5–8]. More than 100 different OPA1 mutations
have been identified, including missense, nonsense, deletion/insertion
and splicing mutations [1,2,13,14]. A few families with sex-influenced
DOA phenotypes have been described [9]. In a study of the sex-
influenced phenotype, we found that vision loss was more severe
amongaffected malesthanfemales, andcaused by the mutation IVS9
+2A.Gi nt h eOPA1 gene [16,17].
Previous studies suggest that OPA1 mutations may cause
multiple organ anomalies. This is supported by several lines of
evidence. First, OPA1 is a ubiquitously expressed protein [1,3].
When mutated, it results in mitochondrial fragmentation, a
decreased mitochondrial membrane potential and decreased
ATP production. The impaired ATP synthesis is associated with
decreased oxygen consumption [10]. Second, OPA1 mutations
affect organs other than the retina [18,19,20,21,22,23,24,25,26].
For example, the R445H mutation causes both optic atrophy and
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6867hearing loss [11–16]. The G401D missense mutation was
identified in a family with optic atrophy and hearing loss,
suggesting that optic atrophy and hearing loss are not R445H
mutation-specific clinical phenotypes. Indeed, it has been reported
that OPA1 mutations are also associated with ptosis and
ophthalmoplegia [27,28,29]. Third, in other mitochondrial
diseases, such as myoclonus epilepsy associated with ragged-red
fibers (MERRF), mitochondrial myopathy, encephalopathy, lactic
acidosis and stroke-like episodes (MELAS), mitochondrion are
fragmented which is associated with proteolytical processing of
OPA1[17]. All of these suggest that OPA1 mutation could cause
multiple organ abnormalities [17] and that analysis of the major
organ systems may extend our knowledge of the clinical
manifestations of OPA1 mutations.
We have developed a Drosophila model of optic atrophy [18]. There
are several advantages to using Drosophila models for studying eye
disorders: 1) significant cost and time savings; 2) eye phenotypes are
easier to detect in Drosophila than in other models; 3) the Drosophila eye is
non-essential for viability. Versatile technologies exist for generating,
identifying and characterizing mutations in the Drosophila retina,
making this an unrivaled system for deciphering gene function. In
addition, there is a high degree of similarity between Drosophila Opa1
and human OPA1[18]. Recently, we generated a Drosophila knockout
model for optic atrophy. Heterozygous mutation of dOpa1 induced by a
P-element or transposon insertion caused no structural abnormalities
under a light microscope, whereas homozygous mutation resulted in
embryonic lethality. In the eye-specific somatic clones, homozygous
mutation of dOpa1 caused rough (mispatterning) and glossy (decreased
lens deposition) eye phenotypes in adult Drosophila and is associated
with increased ROS production [18]. Since OPA1 mutations in
humans cause autosomal dominant phenotypes and heterozygote
mutations display phenotypes, the grossly normal eye in heterozygous
mutant Drosophila under a light microscope could still have abnormal
function and warrant further analysis.
To study OPA1 function and whether the loss of function is
linked to the development of multiple organ abnormalities, we
determined if heterozygous dOpa1 mutation affects the function of
multiple organs and the underlying mechanisms in Drosophila.
Specifically, we examined eye, heart and skeletal muscle in
heterozygous dOpa1 Drosophila mutants. Our result showed that
heterozygous dOpa1 mutation resulted in abnormal electroretino-
grams (ERG) in an age-dependent manner. Abnormal visual
function was also demonstrated in a phototxis assay. The
abnormal ERG and visual dysfunction could be partially rescued
by antioxidant treatment. Heterozygous dOpa1 Drosophila mutants
also showed reduced heart rate, increased heart arrhythmias, and
poor heart function as indicated by decreases in fractional
shortening and increased heart failure in response to electrical
pacing. Additionally, under heat shock stress, the heterozygous
mutants showed reduced escape response suggesting reduced
muscle function. Our results suggest that heterozygous mutation of
dOpa1 could cause multiple organ abnormalities and that ROS
may play a role in the development of some organs, but not others,
suggesting that the pathogenesis could be organ specific.
Results
Heterozygous dOpa1 mutation results in loss of normal
eye function in adult Drosophila and antioxidants can
partially prevent the loss of function
P r e v i o u s l y ,w eh a v ea n a l y z e dt h ee f f e c t so fdOpa1 mutation in
Drosophila eyes. Loss of a single copy of dOpa1 did not elicit a gross eye
phenotype other than morphologically perturbed mitochondria in
transmission electron microscopy (TEM) [18]. To identify subtle
phenotypes, a large cohort of dOpa1
+/2 and dOpa1
+/+ control Drosophila
were aged and their ERG profiles measured every 7 days for 6 weeks.
A ss h o w ni nF i g u r e1 ,h e t e r o z y g o u sm u t a t i o no fdOpa1 resulted in
perturbed ERG profiles in an age-dependent manner. The dOpa1
+/2
mutants showed an age-dependent progressively worsening reduction
in the on-/off-transients beginning at 28 d.o., but no reduction in the
peak amplitude for the six weeks tested (Figure 1). Since the on-
transient, but not the off-transient, is independent of the stimulus
duration, we decided to determine if there were defects in the age-
dependence of the on-transient amplitudes in dOpa1
+/+ and dOpa1
+/2
Drosophila. The ERG response in dOpa1
+/+ flies at 42 d.o., typically
showed an initial transient response (the on-transient) and then a
sustained corneal-negative photoreceptor response followed by an off-
transient when the light stimulus was turned off. ERGs with different
intensities of orange light stimuli, Or,-4 (B), Or,-2 (C), and Or (D), are
superimposed to show the differences in the on-transient amplitudes.
There wasa severe reduction inthe on-transient amplitude in dOpa1
+/2
eyes with brighter Or (D), but not with a dimmer stimulus (B). Our data
showed that in dOpa1
+/+, there was no significant age-dependent
reduction in peak (E) or on-transient amplitudes (G) over the range of
light stimuli tested. However, in dOpa1
+/2, there was a significant age-
dependent reduction in on-transient amplitudes (H) but not in peak
amplitudes (F). Since the on-transient has been shown to be originated
from the laminar monopolar L1 and L2 neurons [19,20], these results
suggest that the dOpa1
+/2 mutation has no apparent effect on
photoreceptor function but has an effect on laminar neuron function
or synaptic transmission between the photoreceptor cells and their
target laminar neurons.
To study the effect of age in detail, on-transient amplitudes were
compared among dOpa1
+/2 Drosophila of different ages. There was
an age-dependent progressive reduction of the on-transient
amplitudes and the defect could be detected over a wider range of
light stimuli in the older dOpa1
+/2 Drosophila (Figure 2). At 28 d.o.,
the on-transient defect in dOpa1
+/2 was only seen with the two
brightest light stimuli (B). At 35 d.o., dOpa1
+/2 showed significantly
reduced on-transient amplitudes with Or,-2, Or,-1, and Or light
stimuli (C). At 42 d.o., reduction in on-transient amplitudes was
manifested in all but the dimmest stimulus in dOpa1
+/2 (D).
To test if the defect found could be reversed by antioxidant
treatment, on-transient amplitudes were determined in 7 to 42 d.o.
Drosophila that were fed with antioxidant-containing diet. As shown
in Figure 2, antioxidant feeding ameliorated the age-dependent
reduction in on-transient amplitudes in the dOpa1
+/2 mutant at all
tested ages. Although the differences in on-transient amplitudes
between dOpa1
+/2 and antioxidant fed dOpa1
+/2 (dOpa1
+/2antiox)
were non-significant, the latter consistently showed larger mean
on-transient amplitudes at all light intensities tested and a slower
reduction in on-transient amplitude with age when compared with
dOpa1
+/+. At 35 d.o., a significant reduction in on-transient
amplitude was seen only with the brightest light stimulus in
dOpa1
+/2antiox (Figure 2E). At 42 d.o., dOpa1
+/2antiox showed
significantly reduced on-transient amplitudes at the brightest two
Or stimuli (F), while dOpa1
+/2 showed a significant reduction over
a wider range of Or light stimuli (D). Thus, antioxidant fed
dOpa1
+/2 delayed the onset of on-transient defect by one to two
weeks. These results suggest that ROS play a very important role
in the pathogenesis of optic atrophy and that antioxidants are a
potential therapeutic agent for this condition.
Heterozygous dOpa1 mutation causes visual
abnormalities in phototaxis and antioxidants can partially
prevent the visual loss
To test if heterozygous dOpa1 mutation affects visual functions at an
earlier stage of fly development, we examined the larval visual system
dOpa1 Mutation
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6867Figure 1. Electroretinogram analyses show an age-dependent reduction in the on-transient but not in the phototransduction
response in heterozygous dOpa1 (dOpa1
+/2) mutants. (A) A typical ERG response showing on-/off-transients and peak amplitude when elicited
with an Or, -2 stimulus. (B) Typical ERGs obtained from 42 d.o. dOpa1
+/+, dOpa1
+/2antiox and dOpa1
+/2 using Or, -4 light stimuli are superimposed. The
on-transients and peak amplitudes from the three Drosophila types are comparable. (C) Typical ERGs from 42 d.o. dOpa1
+/+, dOpa1
+/2antiox and
dOpa1
+/2 during light stimulus with Or, -2 were superimposed. The on-transient, but not the peak amplitudes, from dOpa1
+/2 were smaller than
those of dOpa1
+/+ and dOpa1
+/2antiox. (D) Typical ERGs from 42 d.o. dOpa1
+/+, dOpa1
+/2antiox and dOpa1
+/2 during light stimulus with Or were
superimposed. The on-transients of dOpa1
+/2 and dOpa1
+/2antiox, but not the peak amplitudes, were significantly smaller than those of dOpa1
+/+. (E)
V-log I curves and (G) on-transient amplitudes vs log I from 7, 14, 21, 28, 35 and 42 d.o. dOpa1
+/+ show no age-dependent reduction in on-transient
and peak amplitude responses of the photoreceptor component. V-log I curves from 7, 14, 21,28, 35, and 42 d.o. dOpa1
+/2 show no age-dependent
reduction in peak amplitude responses (F) while the on-transient amplitudes vs log I curves from dOpa1
+/2 show an age-dependent reduction in on-
transient amplitudes (H).
doi:10.1371/journal.pone.0006867.g001
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+/2 heterozygous mutants with a phototaxis assay. This assay
allowed us to measure larval visual phototactic response to light
(Figure 3A). Fifty second-instar larvae were tested in three trials. In the
absence of light, average response indexes (RI) for dOpa1
+/+ and
dOpa1
+/2 were similar (RI=0.072, RI=0.096, respectively, p.0.05)
(Figure 3B). However, with light, dOpa1
+/2 mutants scattered on the
plate showing little visual phototatic response (RI=0.248), while wild-
type dOpa1
+/+ exhibited strong negative phototactic behavior
(RI=0.616, p,0.05) (Figure 3B). These results were replicated using
both dOpa1
+/ex2 and dOpa1
+/in3 Drosophila as discussed in our earlier
paper [18]. Our results suggest that heterozygous mutation of dOpa1
causes loss of visual acuity in Drosophila. This observation is consistent
Figure 2. Heterozygous dOpa1 mutation causes a progressive reduction in on-transient amplitudes in an age-dependent manner
and antioxidants can reduce the progression. (A) dOpa1
+/2 shows no significant reduction in on-transient amplitudes when compared to
dOpa1
+/+ at 7 to 21 d.o. (shown are the 21 d.o. data). dOpa1
+/2 shows significant reductions in on-transient amplitudes with the Or,-1 and Or stimuli
at 28 d.o., (B) and with Or,-2, Or,-1, and Or stimuli at 35 d.o. (C), and at all Or light stimuli except the very dim Or,-4 at 42 d.o. (D) Antioxidant fed
dOpa1
+/2 shows an increase in the mean on-transient amplitudes (A–D), but the increase is not significant when compared to dOpa1
+/2 (E & F, with
error bars shown.). When compared to dOpa1
+/+, at 35 d.o. antioxidant fed dOpa1
+/2 shows a significant reduction in on-transient amplitudes only
with the Or stimulus (E), but not with Or,-2, and Or,-1 as in dOpa1
+/2 (C). At 42 d.o. dOpa1
+/2antiox shows a significant reduction in the on-transient
amplitudes only with Or,-1 and Or (F), but not with Or,-3, and Or,-2 as in dOpa1
+/2 (D). Or=Or light stimulus; Or, -1=Or light stimulus with a log
I/Io=-1 filter to reduced the orange light intensity by 10 fold; Or, -2=Or light stimulus with intensity reduced by 100 fold, Or, -3=1,000 fold reduced
Or light stimulus, and Or, -4=10,000 fold reduced Or light stimulus.
doi:10.1371/journal.pone.0006867.g002
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dOpa1 affects laminar neuron function or synaptic transmission
between the photoreceptor cells and their target laminar neurons.
To test if treatment with antioxidants can improve the visual
function of dOpa1
+/2heterozygous mutants, dOpa1
+/+ and dOpa1
+/2
Drosophila were treated with antioxidant. Again, fifty second-instar
larvae were collected and the phototaxis assay was repeated three
times. In the absence of the light, average RI for dOpa1
+/+ and
dOpa1
+/2 treated with antioxidant were similar (RI=0.107,
RI=0.133, p.0.05) (data not shown). In the presence of light,
antioxidant treatment made no difference in wild-type dOpa1
+/+
(RI=0.667), while mutant dOpa1
+/2 showed a significant increase
in phototatic response (RI=0.427, p,0.05, Figure 3C). These
results suggest that antioxidant treatment can partially reverse
abnormal visual response in dOpa1 mutants. These reversals were
observed both in heterozygous mutant dOpa1
+/in3 and dOpa1
+/ex2.
The partial reverse of ERG response and phototaxis of antioxidant
treatmentsupport ourhypothesis that ROS playsan essentialrole in
the pathogenesis of optic atrophy and antioxidants have the
potential to be an effective therapeutic agent for optic atrophy.
Heterozygous mutation of dOpa1 results in decreased
heart rates and increased cardiac arrhythmias that were
not affected by antioxidant treatment.
Heterozygous mutation of OPA1 has predominantly been
associated with retinal disorders, but recent studies indicate that
it disrupts function of other organs [27,28,29]. Using our Drosophila
model, we tested if heterozygous dOpa1 mutation affects cardiac
function using the methods described by Ocorr et al.[21] Since in
intact Drosophila, the signals from the central nervous system (CNS)
may affect the rate and rhythm of the heart, we removed the
Drosophila head, ventral thorax, ventral abdominal cuticle and all
internal organs as described previously [21]. Drosophila hearts were
then exposed and video recorded for 30 seconds (Figure 4). The
movies were analyzed using the software as described in Ocorr et
al.[21]. Forty Drosophila of each genotype (20 male and 20 female)
were tested at week 3. As shown in Figure 5, heart rate was
significantly reduced in heterozygous dOpa1 mutants (Figure 5, A).
The decreased heart rates resulted predominantly from increased
diastolic intervals, not from changes in systolic intervals (Figure 5,
B). HeterozygousdOpa1 mutation also caused an increase in heart
arrhythmias as shown in Figure 5, C.
There is a sexual dimorphism in overall heart size with female
hearts generally being larger than those of males, as has been
previously reported[22]. Our results show that heterozygous dOpa1-
mutations cause a significant dilation of the heart tube during diastole
(dOpa1
+/+ DD=67.4+/211.8 vs. dOpa1
+/2 DD=76.6+/213.9,
p,0.05) and during systole (dOpa1
+/+SD=38.6+/29.9 vs. dOpa1
+/2
Figure 3. A. Larval phototaxis assay. A plastic petri plate was divided into four quadrants, two dark quadrants diametrically opposite to two clear
quadrants. 1% agarose was used for the clear and 1% agarose containing 0.6% charcoal powder was used for the dark quadrants. 50 second instar
larvae were placed at the center of the plate and were allowed to migrate for 3 minutes in complete darkness for the control, and in the presence of
light by using a light box. The assay was repeated 3 times. Figure 3B. Larval Phototaxis Response Index. 50 second instars were used for each trial
(total of 3 trials each). Wildtype dOpa1
+/+ exhibited strong negative phototatic response in the presence of light (RI=0.616). Heterozygous mutant
dOpa1
+/in3 showed little light response (RI=0.248). Antioxidant treatment made no difference in wildtype dOpa1
+/+ (RI=0.667). Mutant dOpa1
+/in3
treated with antioxidant exhibited a significantly stronger negative phototatic response to light (RI=0.427).
doi:10.1371/journal.pone.0006867.g003
Figure 4. Representative M-mode traces (10 s) of semi-intact
Drosophila from different genotype and sex. M-modes were
created by electronically ‘‘cutting’’ out a single specified vertical row of
pixels that span the heart tube from every frame of the movie, and
aligning them horizontally. The M-modes describe the vertical
movement of the heart walls in time. In these representative M-modes
of 3-week-old dOpa1
+/+ and dOpa1
+/2 Drosophila, it is seen that
mutation causes increased heart period, due primarily to increased
diastolic intervals. The dilation of mutant heart tube is also visible.
doi:10.1371/journal.pone.0006867.g004
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shortening (FS) from the heart diameter measurements as an estimate
of cardiac contractility (33). These results showed that heterozygous
dOpa1 mutations led to a significant reduction in FS (dOpa1
+/+
FS=43.2%+/27.8% vs. dOpa1
+/2 FS=39.5%+/26.7%, p,0.05)
suggesting a loss of myocardial contractility. In order to determine
if excess ROS production played a role in these observed cardiac
abnormalities, we treated the Drosophila with antioxidant (100 mM
MnTBAP). Our results show that antioxidants had no effect on any
of the heart function parameters we measured (Data not shown) in
either wild-type or heterozygous dOpa1mutants. This suggests that
changes in ROS production do not mediate the observed effects of
OPA mutations on the heart. Instead, heterozygous mutation
of dOpa1 leads to a respiratory defect in Complex II and III of
the electron transport chain (ETC) as shown in our recent
publication [23].
Heterozygous mutation of dOpa1 results in increased
heart failure in response to electrical pacing in Drosophila
We also examined the effect of stress on cardiac function in Opa
1 mutants. 80 Drosophila of each genotype (40 male and 40 females)
were tested for heart failure in response to electrical pacing for six
consecutive weeks starting at one week of age. Fly hearts were
paced with external electrical pacing and heart function was
observed immediately following and two minutes after pacing. The
effect on heart function was defined as ‘‘heart failure’’ if the heart
did not resume a normal beating pattern after a two minute rest
period following electrical pacing. Our result showed that heart
failure in response to electrical pacing increased with age in all flies
tested (Figure 6). However, heterozygous dOpa1mutation caused a
significant increase in heart failure when compared to wild-type
controls and this was true for both males and females (Figure 6,
p=1.63e-05), suggesting heterozygous dOpa1mutations compro-
mise heart function in the flies and decrease their ability to tolerate
arrhythmia by stress.
Heterozygous mutation of dOpa1 results in reduced
escape response after stress
To determine the effect of dOpa1 mutation on Drosophila physical
fitness, we quantified the escape responses of dOpa1
+/2 and
dOpa1
+/+ using a previously described technique [24]. Under non-
stress conditions, there were no significant differences between
dOpa1
+/2 and dOpa1
+/+ for all age groups (data not shown). We
then tested if heat-shock stress had an impact on the escape
response of dOpa1
+/2 and dOpa1
+/+ Drosophila. For this experi-
ment, Drosophila in vials were startled by tapping them to the
bottom of the vial. The climbing capacity, before and after a 10-
min 37uC heat shock, was determined by calculating the
percentage of flies that climbed up.1.0 cm within 15 seconds
(locomotive index). The time required for the locomotive index to
exceed 50% (recovery time) was also determined (Figure 7). There
were no differences in climbing capacity before the heat shock.
However, the dOpa1
+/2 mutants exhibited lower locomotive
indexes after the heat shock and were unable to recover within
Figure 5. A. Heterozygous mutation of dOpa1 results in decreased heart rate (p,0.001). Single dashed bars represent dOpa1
+/+ and double dashed
bars represent dOpa1
+/2 Drosophila. Error bars are standard deviation of the mean. Heart rates were recorded at 3 weeks of age. Figure 5B. The
decreased heart rate shown in Figure 5A was predominantly due to an increase in diastolic intervals (,0.001), not an increase in systolic intervals
(0.09).
doi:10.1371/journal.pone.0006867.g005
Figure 6. Heterozygous mutation of dOpa1 results in increased
heart failure (solid line) compared to controls (dashed line).
Heart failure here is defined as cardiac arrest or fibrillation after a two-
minute recovery period following electrical pacing. Heart failure
increased with age for both controls and mutants, but was significantly
higher in mutants. 40 males and 40 females of each genotype were
tested at every age.
doi:10.1371/journal.pone.0006867.g006
dOpa1 Mutation
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+/+ Drosophila recovered within
,10 minutes (Figure 7). These results suggest that under stress,
mutation of dOpa1 causes decreased physical fitness. For cardiac
and skeletal dysfunction, previously two studies showed that OPA1
in humans causes mitochondrial DNA deletion [28,29]. We have
tested this in our Drosophila model. As shown in Supplemental
Figure S1, we see no difference DNA deletion in heterozygous
mutant fly compared with the wild-type. We also used a long range
PCR to test the deletion. The results are very similar (Data not
shown). Instead, heterozygous mutation of dOpa1 leads to a
respiratory defect in Complex II and III of the electron transport
chain (ETC)[23].
Discussion
Mutation of OPA1 can lead to DOA and is one of the most
common genetic causes of degeneration of retinal ganglion cells,
leading to blindness. The main clinical features of DOA include
reduced visual acuity, color vision abnormalities, centrocaecal
visual field defects and pallor of the optic nerve head. However,
the OPA1 gene is ubiquitously expressed and recent studies have
suggested that mutation of OPA1 results in complicated optic
atrophy ‘‘plus’’ phenotypes. These clinical phenotypes include
optic atrophy, as well as neurosensorial hearing loss, ataxia,
sensory motor polyneuropathy and chronic progressive external
ophthalmoplegia. In skeletal muscle of optic atrophy patients,
mutation of OPA1 causes mitochondrial myopathy characterized
by cytochrome c oxidase negative, ragged red fibers and abnormal
morphology and distribution of mitochondria [25]. Since both the
heart and skeletal muscle are the high energy-demanding organs,
mutations of OPA1 may affect the cardiac and skeletal function,
which prompted us to analyze function of multiple organs in our
Drosophila dOpa1 mutant model. Here we show that heterozygous
dOpa1
+/2 mutations not only perturb eye function, but also
decrease cardiac function and decrease escape responses under
stress. These results are consistent with recent studies that
Figure 7. dOpa1 mutation impairs the ability of Drosophila to exhibit a negative geotaxis response following a heat shock. Seven d.o.
Drosophila were places in 962 cm tubes with a line drawn horizontally 1 cm from the base. Every 30 seconds, the tubes were tapped until all
Drosophila were at the bottom of the tubes. A baseline locomotive index (number of Drosophila above the 1 cm line after 15 seconds) was
established at 22uC. Drosophila were then subject to a 20 minute 37uC heat shock and returned to 22uC. Subsequently, the locomotive indexes were
recorded as the samples recovered.
doi:10.1371/journal.pone.0006867.g007
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[18,19,20,21,22,23,24,27,28,29].
An electroretinogram (ERG) is an extracellular recording of the
compound eye and their synaptic targets, the laminar neurons
[19,20]. With an orange light stimulus, a typical wildtype ERG
consists of a sustained corneal-negative photoreceptor component
and transient components at the onset and offset of the light
stimulus. Thus, ERGs can be used to detect defects in both the
photoreceptor response and the response of laminar neurons. The
abnormal on-transient but normal photoreceptor component
obtained with the dOpa1
+/2 Drosophila suggest that photorecptor
function is normal but either laminar neuron function or synaptic
transmission between the photoreceptor and the laminar neuron is
impaired. Based on the correlation with age and the fact that
antioxidants partially rescued the phenotype of ERG and vision
loss, our results suggest that high ROS levels contribute to the
phenotypes, which is consistent with our previous results that
somatic mutation of dOp1 may cause increased ROS production
[18].
A number of studies have implicated mitochondrial defects in
cardiac dysfunction. Mitochondrial dysfunction can cause de-
creased ATP production and/or increased ROS production, and
either outcome can lead to cardiac cellular damage. Mutations
affecting mitochondrial function have been shown to cause Leber’s
Hereditary Optic Neuropathy (LHON), MERRF, MELAS,
Chronic Progressive External Ophthalmoplegia (CPEO),
Kearns-Sayre Syndrome (KSS), and various other pediatric and
adult cardiomyopathies. In Friedreich ataxia, mutations occur in
the nuclear frataxin gene. Frataxin encodes a mitochondrial inner
membrane protein, which transports iron out of the mitochondrial
matrix. In the absence of frataxin, iron accumulates in the
mitochondria, stimulating the Fenton reaction and ROS produc-
tion [26,27]. However, our result show that antioxidants do not
improve cardiac abnormalities caused by dOpa1 mutations,
suggesting that these mutations result in cardiac dysfunction
primarily by affecting mitochondrial ATP production rather than
by increasing ROS production.
Mitochondrial dysfunction has been associated with many
skeletal abnormalities such as MERRF. Recently, two groups
reported that several OPA1 mutations cause ‘‘optic atrophy plus
syndrome’’. In addition to optic atrophy, the clinical phenotypes of
‘‘optic atrophy plus syndrome’’ was reported [27,28,29]. The
mitochondrial diseases MERRF, and MELAS are cuased by
mutations of the mitochondrial genome, but associated with
abnormal proteolytically processing of OPA1 [17]. Taken
together, this supports the hypothesis that OPA1 mutations cause
skeletal abnormalities [27,28,29]. Our result showed that hetero-
zygous dOpa1 mutation caused reduced escape response, suggest-
ing the possibility of abnormal function of the skeletal muscles.
The analysis of the effect of dOpa1
+/2 on Drosophila organ
systems showed that organ dysfunction developed in an age-
dependant manner, consistent with the clinical optic atrophy
phenotype. In humans, the onset of most optic atrophies is in
childhood and the pathologies typically include progressive
bilateral loss of visual acuity, abnormal color vision [5–8], and
temporal pallor of the optic disk [28]. The loss of visual acuity is
caused by a decrease in the number of optic nerve fibers in the
central retina. The age-dependent phenotypes suggest cumulative
damage and this is consistent with our observation that dOpa1
mutation results in increased ROS production and accumulation
in eyes[18]. Together, these observations partially explain the
significant intra- and inter-familial variations in vision loss, the
incomplete penetrance of the disease and sex dependent
phenotype [9,16,17,41] since estrogen receptors in mitochondria
may play an antioxidant contributing to the observed sex
influenced eye phenotypes [29].
Dominant optic atrophy is one of the most common forms of
inherited optic neuropathy [5]. The etiology is heterogeneous and
many inheritance patterns have been described, including
autosomal dominant, autosomal recessive, X-linked and mito-
chondrial. Importantly, several other optic atrophies share
pathophysiology with DOA and, therefore, the results from this
study can be extended to other types of optic atrophy and
neurodegenerative disease. Moreover, mutation of OPA1 causes
mitochondrial dysfunction, including fragmentation, decreased
ATP production, increased ROS production and decreased
mitochondrial membrane potentials [10]. Abnormalities of
mitochondrial fusion and fission have been reported in several
mitochondrial disorders [43,44]. Together, this suggests that
OPA1 mutations cause multiple organ abnormalities, including
auditory neuropathy, peripheral neuropathy (apoptosis and
ophthalmoplegia), cardiomyopathy and myopathy, suggesting that
OPA1 could be a common target for treatment of mitochondria-
related disorders.
Materials and Methods
Drosophila stocks
y[d2] w[1118] P{ry[+t7.2]=ey-FLP.N}2; P{ry[+t7.2]=
neoFRT}42D PBac{WH}CG8479
f02779 (dOpa1
+/2) and y[d2]
w[1118] P{ry[+t7.2]=ey-FLP.N}2; P{ry[+t7.2]=neoFRT}42D
PBac{WH}CG8479
f03594 (dOpa1
+/+) Drosophila were used in this
study. The stocks were established in a previous study [18].
dOpa1
+/2 mutants and dOpa1
+/+ controls were transferred to fresh
food every two to three days while aging. dOpa1
+/2(antiox) Drosophila
and dOpa1
+/+(antiox)Drosophila were maintained on 100 mM
MnTBAP antioxidant food.
Electroretinograms (ERG)
ERGs were performed as previously described [31] on 7, 14, 21,
28, 35, and 42 d.o. Drosophila. A 300-Watt Halogen lamp
(OSRAM) with an unattenuated intensity of 810 mW/cm
2 at the
level of the photoreceptors was used for light stimuli. Kodak
neutral filters and a Corning orange (Or) filter were used to
achieve the desired light intensity and color for the light stimuli.
For each stimulus, the Drosophila was first dark-adapted for 3
minutes and then given a 1 second light stimulus. Orange light
stimuli were used because they elicit larger on-transient amplitudes
than white light stimuli. All recordings were made at 25uC. Signals
were sampled at 2 kHz with an analog-to-digital converter
(Digidata 1200A), and the data were acquired and analyzed using
a computer with Axoscope (Axon Instruments).
Larval phototaxis assay
The phototaxis assay tested larval visual response using methods
according to Lilly and Carlson [32]. Plastic petri plates were
sectioned into four quadrants, two dark quadrants diametrically
opposite to two clear quadrants. 20 ml of 1% agarose was poured
into the clear quadrants, and 20 ml of 1% agarose containing
0.6% charcoal powder was poured into the dark quadrants. After
the plates cooled to room temperature, 15 ml of 1% agarose was
poured evenly on the gel to create a smooth surface. The plates
were allowed to equilibrate to room temperature overnight. Thick
black papers were used to cover the sides of the plates, and to
cover underneath the plates in regions of the dark quadrants to
reduce light reflection. 50 second-instar larvae were placed on the
center of the experimental test plate. The plate was placed in total
darkness and the larvae were allowed to migrate for 3 minutes for
dOpa1 Mutation
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black foam to reduce light reflection and then it was placed on a
light box in a dark room. The larvae were allowed to migrate for 3
minutes. Response index (RI) was calculated by subtracting the
number of larvae on the clear quadrants (C) from the number of
larvae on the dark quadrants (D) all divided by the total larvae
used, RI=(D – C)/(D+C).
Cardiac function analysis
Drosophila were dissected under an oxygenated saline solution that
served as artificial hemolymph, composed of NaCl2 (108 mM), KCl
(5 mM), CaCl2 (2 mM), MgCl2 (8 mM), NaH2PO4 (1 mM),
NaHCO3 (4 mM), HEPES (15 mM), sucrose (10 mM), trehalose
(5 mM), pH 7.1,as described previously [34,47,48] A Hamamatsu
EM-CCD digital camera (McBain Instruments,Chatsworth, CA)
mounted on a Leica DM LFSA microscope with a 10 x water
immersion lens (McBain Instruments, Chatsworth, CA) and Simple
PCI image capture software (Compix Imaging System, Selwicky, PA)
was used to digitally record beating hearts in semi-intact Drosophila
preparation [21]. All movies were taken 15–45 minutes following
dissection, were 30 seconds long, and were taken as frame rates of
approximately 130 frames per second. The movement of the heart
was analyzed using a previously described software [34,47]. The
software tracks movement of the heart edges using both changes in
average light intensity of each frame and changes in the intensity in
each individual pixel from frame to frame. M-modes were created by
the software by electronically ‘‘cutting’’ out a single specified vertical
row of pixels that span the heart tube from every frame of the movie,
and aligning them horizontally. The M-modes describe the vertical
movement of the heart walls in time. Diastolic intervals were
measured as the pause in movements occurring during relaxation.
The time between the ends of two consecutive diastolic intervals gave
the heart period, and the difference between the heart period and the
diastolic intervals gave the systolic interval. The arrhythmicity index
(AI) is the heart period standard deviation normalized to the median
heart period to compensate for variabilities between flies and for
effects on periodicity due to prolonged contractions[21]. Diastolic
and systolic diameters were measured by marking the edges of the
heart tube in maximum contraction and maximum relaxation states
in manually advanced movies. Markings were made in the third
abdominal segment, which is a relatively linear region of the heart
tube. Percent fractional shortening was calculated as (Diastolic
diameter – Systolic diameter)/Diastolic diameter. % FS isthe fraction
of relaxed diameter size that the heart shortens to when it contracts
and thus gives an estimate of the contractibility of the heart tube. We
tested for population and sex effects and population by sex
interactions by ANOVA in R (www.r-project.org).
Cardiac pacing assay
Drosophila heart function was tested using an electrical pacing
assay as previously described[49]. Briefly, Drosophila were anesthe-
tizes by exposing to triethylamine (FlyNap
TM; Caroline Biological,
Burlington, NC, USA), and were placed on glass microscope slides
with their heads and posterior abdomens touching two strips of
conductive electrode gel. A square wave stimulator was used to
pace the heart at 40V and 6 Hz for 30 s. The assay was done
under an inverted microscope and an X25 objective. Each
Drosophila was visually checked for cardiac arrest or fibrillation
immediately after pacing and then two minutes after pacing. Data
were analyzed using a Chi-square test.
Locomotive Assay
Drosophila were placed in 962 cm tubes with a line drawn
horizontally 1 cm from the base. Every 30 seconds, the tubes were
tapped until all Drosophila fell to the bottom of the tubes. A baseline
locomotive index (number of Drosophila above the 1 cm line after
15 seconds) was established at 22uC. The Drosophila were then
subjected to a 20 minute 37uC heat treatment and returned to
22uC. The locomotive indexes were recorded as the samples were
allowed to recover [24].
Supporting Information
Figure S1 dOpa1+/2 Drosophila is not associated with major
mitochondrial DNA deletions. Total genomic DNA from 3 wk
and 6 wk old dOpa1+/2 and dOpa1+/+ flies were fractionated
by agarose gel electrophoresis,visualized by ethidium bromide
staining and then transferred to nylon membrane. Digoxigenin-
tagged DNA probe (Long PCR products spanning positions
1,867–14,744 of the Drosophila mtDNA (Panel A) were generated
by random primer labeling, hybridized to target sequences, bound
by anti-digoxigenin-AP, Fab fragments, and then detected with
CDP-Star (Roche). Panel B, Southern blot for mitochondrial
genome, showing a very similar pattern in dOpa1+/2 and
dOpa1+/+ (Panel B).
Found at: doi:10.1371/journal.pone.0006867.s001 (0.40 MB
DOC)
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